Frail older adults often experience swallowing disorders, prompting nursing staff to crush tablets, open capsules, and mix drugs into their meals or gelled water. However, crushing drugs can lead to pharmacological and gustatory problems. As crushed drugs can stay in prolonged contact with oral microbial biofi lm, the current study aimed to investigate their antimicrobial properties. Crushed drugs were diluted in 1 mL of isotonic water and assayed in vitro for: (a) growth inhibition of fi ve bacterial strains and Candida albicans by the diff usion method; (b) inhibition of Streptococcus salivarius and C. albicans biofi lm formation; and (c) elimination of a preformed biofi lm of S. salivarius and C. albicans after 5-minute contact. Eight of 29 crushed drugs inhibited bacterial and/or fungal growth on agar plates. Twenty-eight of 29 crushed drugs reduced the total biomass when incubated with S. salivarius, and 28 of 29 crushed drugs inhibited C. albicans biofi lm formation. Preformed biomass was reduced by ≥25% by seven of 29 drugs. Crushed drugs may unbalance oral ecosystems and contribute to oral infl ammation.
Oral care for frail older adults is currently a problem for nurses and nurse's aides in charge of oral health care (Chen, Naorungroj, Douglas, & Beck, 2013) . Heavy dental plaque load is commonly observed, despite correct application of oral hygiene protocols. Several risk factors have been identifi ed, such as oral dryness or daily use of antiseptic mouthwashes that unbalance the oral ecosystem. Th e current authors hypothesized that some nonantimicrobial drugs could also display antimicrobial properties when crushed and applied directly in contact with oral biofi lms, thus altering the oral ecosystem. If this hypothesis is verifi ed, the fi ndings would help reduce side eff ects of crushed medications by reinforcing current recommendations on crushing drugs.
Th e endogenous oral biofi lm that colonizes oral surfaces is integral to good oral health, along with saliva, a healthy diet, and oral hygiene (Krom, Kidwai, & Ten Cate, 2014) . Metagenomics methods have shown that the oral microbiome contains thousands of bacterial and hundreds of fungal species, as well as Archeabacteria, parasites, and viruses. However, <700 bacterial species and only a few fungal species can be grown in vitro from oral samples, whereas cultivable and uncultivable species play a role in health and disease (Diaz, Strausbaugh, & DongariBagtzoglou, 2014 ).
An individual's mouth harbors approximately 100 cultivable microbial strains. Conventional and DNA/RNAbased analyses are time-consuming, expensive, and wholly impractical for routine dental examination, whereas clinical examination and radiographs can immediately diagnose dental and periodontal diseases (Larsen & Fiehn, 2017; Socransky et al., 2013) . However, cariogenic and periodontogenic biofi lms diff er from individual-to-individual and site-to-site in the same mouth, and they evolve over time.
In vitro screening experiments to assay antiseptic products or disinfection protocols are based on monospecies biofi lm models. Experimental models of multispecies biofi lms generally combine two to 10 cultivable bacterial and fungal species. Th e reason is that multispecies culture is made diffi cult by the fact that unlike Candidas albicans, most oral bacteria are slow-growing, nutritionally fastidious, and oxygen-sensitive. Table A (available in the online version of this article) details the prominent cultivable organisms found in the mouth (Chevalier, Ranque, & Prêcheur, 2017) .
In vivo, oral microorganisms are protected by a matrix that enables specialized biofi lms to colonize soft and hard surfaces in the mouth (Diaz et al., 2014) . Th e dynamic balance between host and biofi lm prevents uncontrolled microbial growth and creates a commensal protection against opportunistic pathogens (Larsen & Fiehn, 2017; Peterson et al., 2014) .
Any factor able to unbalance oral ecosystems can lead to uncontrolled microbial growth, which creates a risk for oral infection (e.g., gingivitis, periodontitis), dental caries and endodontic infections, oral candidiasis, mucositis, and peri-implantitis (Peterson et al., 2014; Socransky et al., 2013) . Oral infections are oft en complicated by pain, tooth loss, and weight loss. Microbial deposits can lead to aspiration pneumonia and blood-borne infections such as infectious endocarditis, or brain, liver, and other deep abscesses (Ewan et al., 2010) .
Oral infections and the resulting infl ammation also increase the risks for systemic diseases such as diabetes mellitus, rheumatoid arthritis, neurodegenerative disease (e.g., Alzheimer's disease), atherosclerosis, cardiovascular disease, and stroke (Dietrich, Sharma, Walter, Weston, & Beck, 2013; Holtfreter et al., 2013; Otomo-Corgel, Pucher, Rethman, & Reynolds, 2012; Silva et al., 2015) .
Oral hygiene aims to prevent the uncontrolled microbial growth that results in macroscopic deposits. When frail older adults cannot use a toothbrush and toothpaste, nursing staff use an oral rinse on a cotton swab or other device. However, daily use of antiseptic mouthwashes containing chlorhexidine and alcohol can induce oral candidiasis and xerostomia (Chevalier, Sakarovitch, Prêcheur, Lamure, & Pouysségur-Rougier, 2015) . Consequently, crushing drugs and opening capsules could alter oral ecosystems, with xerostomia, poor access to oral care, and disability further impairing oral hygiene.
Crushing drugs is a common practice in institutional care settings, where more than 50% of residents have swallowing disorders. Swallowing disorders are behavioral conditions associated with cognitive impairment (e.g., Alzheimer's disease), stroke, cancer, Parkinson's disease, Sjögren's syndrome, or certain xerostomia-inducing medications. Th e resulting dysphagia increases the risk of aspiration pneumonia, choking, and death (Ewan et al., 2010) , whereas food and beverage refusal can lead to dehydration, anorexia, and malnutrition. As a precaution, these patients are oft en given blended food. Nursing home staff will oft en crush tablets, open capsules, and mix drugs into textured (oft en blended) food or gelled water-a strategy used for 28% to 33% of residents, and up to 67% of patients in geriatric hospital units (Apolo Carvajal et al., 2016; Clauson, Rull, Th ibault, Ordekyan, & Tavernier, 2016; Sura, Madhavan, Carnaby, & Crary, 2012) .
Listings of "safe-to-crush" drugs and consensus guidelines for their administration have been published by several groups of experts (Institute for Safe Medication Practices, 2015). For instance, in a listing of the 30 most prescribed drugs in a group of nursing homes, approximately one half of the tablets and capsules were listed "safe for crushing, " including paracetamol (acetaminophen), furosemide, memantine, zopiclone, alprazolam, oxazepam, donepezil, clopidogrel, ramipril, folic acid, amiodarone, citalopram, fl uindione, digoxin, and galantamine. Conversely, aspirin, potassium chloride, amlodipine, ris-peridone, mianserin, calcium carbonate, cholecalciferol, calcium carbonate/cholecalciferol benserazide/levodopa, rivastigmine, trinitrine, esomeprazole, and domperidone were not safe for crushing (Institute for Safe Medication Practices, 2015) .
Th e guidance on crushing drugs states that physicians should limit drug prescription, pharmacists should propose alternative formulations such as oral drops whenever possible, and nurses should crush only drugs cleared as crushable. Medications should be crushed separately just before administration, and mixed into separate food servings. However, despite these recommendations, it is still common practice for "do not crush" medications to be given crushed, or given crushed together with other drugs and co-administered in the same food serving (Apolo Carvajal et al., 2016; Clauson et al., 2016) .
Crushing drugs and opening capsules can lead to chemical (e.g., oxidization, acid-base interactions) and pharmacological (e.g., gastro-resistant or extended-release tablets) problems. Th e taste of some drugs, such as docusate, zopiclone, clopidogrel, and paracetamol, may be unbearable when crushed and mixed into food, and the experience is even worse when these medications are crushed and mixed all together . Th e unbearable bitter taste of some crushed drugs could lead to food refusals and ultimately contribute to anorexia in frail older adults (Institute for Safe Medication Practices, 2015; Lamure et al., 2015) .
Some drugs have known antimicrobial eff ects, such as aspirin and ibuprofen (Akhter, Baqai, & Aziz, 2010; Laudy, Mrowka, Krajewska, & Tyski, 2016; Ogundeji, Pohl, & Sebolai, 2016; Rusu, Radu-Popescu, Pelinescu, & Vassu, 2015) and amlodipine (Dutta, Mazumdar, DasGupta, & Dastidar, 2009; Gupta, Chanda, Rai, Kataria, & Kumar, 2016) . Crushing drugs exposes the oral microbial biofi lm to prolonged contact, especially in patients that have swallowing disorders and xerostomia. Th e question of whether some crushed drugs, in addition to chemical interactions and taste alterations, could also have intrinsic antimicrobial properties and alter the protective microbial biofi lm in the mouth remains unanswered. To address this gap, the aim of the current study was to screen in vitro the antimicrobial properties of drugs commonly prescribed in nursing homes. Th e null hypothesis was that crushed drugs have no eff ect on microbial growth, biofi lm formation, and biofi lm reduction.
METHOD
Mandatory health and safety procedures were complied within the course of performing all experimental work.
Crushed Drugs
Th e 30 drugs tested were selected as the top drugs prescribed in 2013 in 290 nursing homes (Table B, available in the online version of this article). Th e drugs were obtained from the university hospital pharmacy at the lowest dosage available. Tablets were crushed manually with a mortar and pestle. Th e crushed tablets, opened capsules, and powders were diluted in 1 mL of isotonic water and pH-tested before performing microbial assays.
Microbial Growth Inhibition on Agar Plates
Th e microbial assay methods used are described in Chevalier, Médioni, and Prêcheur (2012) . Briefl y, drugs' antibacterial properties were tested using fi ve bacterial reference strains: Escherichia coli CIP 54.127, Staphylococcus aureus CIP 53.154, Pseudomonas aeruginosa CIP A22, and two oral species Streptococcus salivarius CIP 102.505 and Gemella haemolysans CIP 101.126. A fungal reference strain of Candida albicans ATCC 10231 was also tested.
Microbial growth inhibition was investigated by the diffusion method with 100 μL of bacterial (10 8 colony forming unit [cfu]) or fungal (10 6 cfu) inoculum smeared on agar plates, and 40 μL of drug solution deposited into 5-mm diameter wells. Diameter of growth inhibition zone was measured aft er 24 or 48 hours of incubation at 37°C. Th e variable was the diameter of inhibition zone around the wells in the agar plates, and results were expressed in mm ( Figure A , available in the online version of this article).
E. coli, S. aureus, and P. aeruginosa are not regular members of oral microbiome (Table A) . However, E. coli, S. aureus, P. aeruginosa, and C. albicans were specifi cally tested as these four strains are recommended by the French National Standardization Agency (Agence Française de Normalisation, 2010) as reference strains for testing antimicrobial compounds.
Th e preliminary panel was completed by adding two oral species, S. salivarius and G. haemolysans, as they are commonly isolated from saliva and oral biofi lm samples in health and disease ( Table A) . Th ese two oral species have complex nutritive needs, including iron, and are grown on agar supplemented with 5% sheep blood. Th eir enzymatic machinery causes lysis of red cell membrane and iron binding.
Eff ect of Drugs on the Formation of S. salivarius and C. albicans Biofi lms
S. salivarius and C. albicans biofi lms were grown on commercially available pre-sterilized, polystyrene, fl atbottomed 96-well microtiter plates. Biofi lms were formed by pipetting 100 μL of cell suspensions into the wells: suspensions contained 10 8 mL -1 S. salivarius cells in Schaedler broth or 10 6 C. albicans cells mL -1 in Roswell Park Memorial Institute (RPMI) 1640 medium buff ered with 3-(N-morpholino)-propanesulfonic acid (MOPS).
Eff ect of Crushed Drugs on Biofi lm Formation. To determine whether drugs had an eff ect on biofi lm formation, 50 μL of each crushed drug solution was added to the wells. Isotonic water was used as a negative control. As a positive control, a mouthwash containing chlorhexidine gluconate (0.5% v/v), chlorobutanol hemihydrate (0.5% w/v), levomenthol, and ethanol (Eludril®) was selected. Chlorhexidine is a disinfectant and antiseptic agent eff ective against a range of bacteria, viruses, bacterial spores, and fungi. In vivo, chlorhexidine prevents the formation of dental plaque. Chlorobutanol is also an antiseptic agent that kills bacteria and fungi (Osso & Kanani, 2013) .
Plates were incubated for 48 hours (S. salivarius) or 24 hours (C. albicans) at 37°C on an orbital shaker at 100 rpm. Aft er biofi lm formation, the medium was aspirated, and nonadherent cells were removed by thoroughly washing the biofi lms twice with phosphate buff er saline (PBS, pH 7.2).
For S. salivarius, the quantifi cation of biofi lm total biomass was performed by crystal violet staining. Briefl y, the wells were added with 150 μL of crystal violet (1% v/v) and incubated for 15 minutes at 37°C. Th e plates were washed again and air-dried, then added with 200 μL of 95% ethanol and shaken for 5 minutes to suspend intracellular-bound crystal violet before measuring optical density (OD) at 630 nm. Th e variable was OD (unitless) of bacterial culture in the violet-colored microtiter plate wells ( Figure A) .
For C. albicans, a semi-quantitative measure of biofi lm formation was obtained using the XTT reduction assay. Th e variable was OD of fungal culture in the orangecolored microtiter plate wells ( Figure A) .
Eff ect of Crushed Drugs on Preformed Biofi lms.
To determine whether drugs had an eff ect on a preformed biofi lm, S. salivarius and C. albicans biofi lms were obtained as described above. Aft er incubation for 48 hours (S. salivarius) or 24 hours (C. albicans) at 37°C, the growth medium was aspirated, nonadherent cells were removed by thoroughly washing the biofi lms with PBS, and 100 μL of crushed drug solution was added to the wells. Plates were incubated for 5 minutes on an orbital shaker at 100 rpm. For this experiment, the protocol described by Chevalier et al. (2012) was re-adapted to test plant extracts for crushed drugs. Preformed biofi lms were incubated for 5 minutes instead of 2 hours to mimic a real-world situation with frail older adults with swallowing disorders. Aft er washing the biofi lms, the crystal violet or XTT reactions were measured to evaluate the biomass or reduction of cell viability in a preformed biofi lm.
RESULTS

Medications and pH Measures
Th e 30 drugs most oft en prescribed in nursing homes and studied herein are listed in Table B , along with their formulae, formulations, main indications, pH, and safe-tocrush/do-not-crush status.
Th e most frequently prescribed drug was paracetamol, followed in decreasing order by aspirin, furosemide, levothyroxine, memantine, potassium chloride, zopiclone, amlodipine, alprazolam, oxazepam, risperidone, mianserin, donepezil, macrogol 4000, clopidogrel, calcium carbonate/ cholecalciferol, benserazide/levodopa, ramipril, folic acid, amiodarone, rivastigmine, glycerol, citalopram, fl uindione, digoxin, trinitrine, esomeprazole, galantamine, cholecalciferol, and domperidone.
Glycerol suppository was excluded from microbial assays. Aspirin and benserazide/levodopa in powder form were tested because severe cases of swallowing disorders carry a risk of choking when drinking water, so patients are given gelled water instead, in which case powder may be administered in the gelled water, similarly to crushed tablets and opened capsules.
For the 29 drugs tested, pH in solution ranged from 5 (clopidogrel and fl uindione) to 8.5 (macrogol 4000 and calcium carbonate/cholecalciferol). pH < 6 favors the development of dental caries (Chevalier, Ranque, & Prêcheur, 2017; Larsen & Fiehn, 2017) . Clopidogrel and fl uindione were the only drugs with an acidic pH < 6.
Microbial Growth Inhibition
All assays were performed in triplicate. Eight of 29 drugs inhibited bacterial and/or fungal growth on agar plates (Table, Figure A , and Table C [available in the online version of this article]).
In addition to antimicrobial properties, hemolytic properties were screened by measuring diameter of hemolysis on 5% sheep blood agar plates. Results, in decreasing order, were: galantamine, 26 mm (SD = 1.4 mm); benserazide/ levodopa, 17.5 mm (SD = 3.5 mm); clopidogrel, 12.5 mm (SD = 2.1 mm); amlodipine, 11 mm; alprazolam, 9.5 mm (SD = 0.7 mm); citalopram, 8 mm (SD = 2.8 mm); domperidone, 8 mm; mianserin, 7 mm; amiodarone, 6 mm; and potassium chloride, 6 mm. Among these 10 active ingredients, three (i.e., amiodarone, domperidone, potassium chloride) displayed hemolytic activity but no inhibition of bacterial or fungal growth.
Streptococcus salivarius Biofi lm
All drugs tested, except clopidogrel, reduced the biofi lm total biomass when they were incubated with S. salivarius during biofi lm formation (Figure 1 and Figure B [available in the online version of this article]). Th ese drugs were at least as effi cient at reducing biomass as the chlorhexidine mouthwash that served as antimicrobial reference (36.4% [SD = 0.5%] residual biomass compared to 100% control untreated biofi lm).
Aft er 5 minutes of contact exposure of a 24-hour preformed biofi lm to chlorhexidine mouthwash, 69.2% (SD = 4.3%) residual biofi lm was observed. Six drugs were able to reduce the bacterial biomass by ≥25% (i.e., paracetamol, aspirin, amlodipine, alprazolam, risperidone, and rivastigmine; Figure 1 and Figure C [available in the online version of this article]). In both experiments, during biofi lm formation or with a preformed biofi lm, none of the drugs tested increased bacterial growth or biofi lm formation: values >100% resulted from drug-dye (crystal violet) interactions.
Candida albicans Biofi lm
All drugs tested, except macrogol, reduced fungal cell viability when incubated with C. albicans during biofi lm formation (Figure 2 and Figure D [available in the online version of this article]). Th ree drugs were as effi cient as the chlorhexidine mouthwash and totally inhibited C. albicans growth (i.e., aspirin, amlodipine, and alprazolam). Twelve additional drugs reduced Candida viability by ≥75%, in decreasing order of effi cacy: memantine, potassium chloride, paracetamol, cholecalciferol, donepezil, amiodarone, fl uindione, levothyroxine, oxazepam, furosemide, esomeprazole, and risperidone.
Th e chlorhexidine mouthwash effi ciently reduced the 24-hour preformed C. albicans biofi lm. Aft er 5 minutes of contact, there was only 4.2% (SD = 0.5%) residual biofi lm 
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in the wells. Only one drug, amlodipine, was able to reduce the bacterial biomass by approximately 25% (Figure 2 and Figure E [available in the online version of this article]).
In both experiments, none of the drugs tested increased fungal growth or biofi lm formation: values >100% resulted from drug-dye (orange XTT) interactions.
DISCUSSION
To the current authors' knowledge, this is the fi rst study to show that some crushed drugs have antimicrobial properties in vitro and could contribute to altered oral biofi lm and thus increase risk of oral infections.
Some drugs also displayed hemolytic properties at the concentrations tested. Th is result was not anticipated, but must be considered, because occult bleeding is frequent in the mouth due to gingival infl ammation during gingivitis and periodontitis (Otomo-Corgel et al., 2012) . Th is unexpected result suggests that some drugs could induce red cell lysis, providing iron and other nutrients to fastidious oral germs, and thus contribute to unbalanced oral biofi lm.
Th e 29 most prescribed drugs in nursing homes were screened and evaluated according to whether they were safe to crush or listed as "do not crush" (Institute for Safe Medication Practices, 2015), because in practice, nursing home staff do not always follow the guidance on crushing (Apolo Carvajal et al., 2016; Clauson et al., 2016) .
Th e model using agar plates did not refl ect the eff ects of these compounds on oral biofi lm, but was used as a convenient preliminary screening method. However, on agar plates, eight of 29 drugs inhibited the growth of E. coli, P. aeruginosa, S. aureus, G. haemolysans, S. salivarius, and/or C. albicans . Each drug had a diff erent antimicrobial profi le. Amlodipine, citalopram, and clopidogrel were active against all fi ve bacterial strains tested, whereas alprazolam only inhibited S. aureus, and amlodipine, mianserin, and citalopram were active against C. albicans.
Th e methodology is open to criticism. Th e active ingredients were tested combined with excipients, and suspension in 1 mL of isotonic water may not have ensured perfect dilution of crushed tablets or capsules content in the agar plates. However, these conditions were similar to drug delivery protocols for individuals with dysphagia (Apolo Carvajal et al., 2016; Clauson et al., 2015; Sura et al., 2012) . Further investigations are needed to test more crushed drugs, alone and in combination. Polymicrobial bacterial-fungal biofi lms should also be tested, despite the fact that highly complex oral biofi lms cannot be modeled in vitro (Diaz et al., 2014; Lauritano et al., 2016) .
Th e study was a preliminary screening and did not intend to test the eff ect of crushed drugs on mixed fungalbacterial biofi lms. Only two model monospecies biofi lms grown with S. salivarius and C. albicans were tested, but this approach was suffi cient to observe in vitro antimicrobial properties of the 29 drugs tested.
Th is was an observational study, without statistical analysis, as the authors did not intend to reduce any one given organism because abscessed teeth and periodontal infections are always treated with presumptive antibiotic treatment, which is not targeted against a specifi c bacterial species but against the faster-growing whole microbial population. Th e key fi nding of the current study is that crushed medications may unbalance oral ecosystems.
Antimicrobial properties of crushed drugs against dental plaque, respiratory pathogens, or C. albicans could appear as a positive side eff ect for frail older adults (Ortega et al., 2015) . However, the current study demonstrated that crushing drugs and opening capsules could alter oral ecosystems. Th ese results could also apply to drug excre- 
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tion in saliva and explain why a strong association exists between xerostomia and medications of any given pharmacotherapy family (Nederfors, Isaksson, Mornstad, & Dahlof, 1997) .
Crushing may also induce local allergic contact, burns, or injuries to oral mucosa, especially with aspirin and other drugs such as clopidogrel or fl uindione, which have a low pH aft er crushing (pH 5). Acidity favors dental caries and C. albicans outgrowth (Koopman et al., 2015) . Furthermore, crushing drugs and opening capsules may also induce allergies among nurses who prepare medications and mix them into food or gelled water (Akhter et al., 2010; Laudy et al., 2016; Ogundeji et al., 2016) .
No chemical similarities to antibiotic or antifungal agents were found in the current study ( Table B) ; however, antibacterial and/or antifungal properties of aspirin, amlodipine, and benserazide/levodopa have previously been described in vitro (Akhter et al., 2010; Kruszewska, Zareba, & Tyski, 2012) . Amlodipine, mianserin, and citalopram may also have antiparasitic properties. Review of the literature failed to fi nd other antimicrobial properties attributed to the drugs tested in the current study, or to their excipients.
Aspirin inhibits the growth of many Gram-negative and Gram-positive bacteria (Akhter et al., 2010; Demirag, Esen, Zivalioglu, Leblebicioglu, & Keceligil, 2007) . Aspirin can alter the production of S. aureus capsular polysaccharides, unmasking surface adhesions and increasing their capacity to invade epithelial cells (Alvarez et al., 2010) , which could facilitate the persistence of S. aureus in the oral cavity (Ortega et al., 2015) . Aspirin also inhibits the growth of Candida spp. and Cryptococcus spp. (Farrugia, Bannister, Vassallo, & Balzan, 2013; Ogundeji et al., 2016; Rosato et al., 2016; Rusu et al., 2015; Yang, Liao, Cong, Lu, & Yang, 2016) . Aspirin could increase antifungal susceptibility in Candida spp. (Rosato et al., 2016) and decrease antibiotic susceptibility in some bacterial species (Laudy et al., 2016) .
Amlodipine is an inhibitor of voltage-gated Ca 2+ channels in mammals and parasites, and can inhibit the growth of S. aureus, E. coli, P. aeruginosa (Kruszewska et al., 2012) , Listeria monocytogenes (Dutta et al., 2009) , C. albicans, and Candida glabrata (Gupta et al., 2016) . Benserazide can inhibit the growth of Prevotella spp. (Wang, McKain, Walker, & Wallace, 2004) , and benserazide/levodopa could have some antibacterial properties in vitro, especially against S. aureus (Kruszewska et al., 2012) .
Parasites such as Entamoeba gingivalis or Trichomonas tenax can oft en colonize deep periodontal pockets (Lauritano et al., 2016) . Amlodipine can inhibit the growth of Acanthamoeba spp. (Baig, Iqbal, & Khan, 2013) , Leishmania spp., and Trypanosoma cruzi (Reimao, Scotti, & Tempone, 2010) . Mianserin kills Leishmania donovani by depleting ergosterol levels (Dinesh, Kaur, Swamy, & Singh, 2014) . However, the putative impact of crushed amlodipine or mianserin against oral parasites is unknown.
CONCLUSION
In addition to creating pharmacological problems and potentially inducing anorexia, many crushed medications could unbalance oral ecosystems, and thus contribute to the development of uncontrolled microbial deposits in the mouth, increasing risks for oral infl ammation, oral pain, oral infections, and aspiration pneumonia among frail older adults. Based on the current study results, there is a risk with virtually all drugs tested, with each drug displaying a specifi c antimicrobial profi le according to the microorganisms tested. However, caregivers of patients with swallowing problems or cognitive disorders may have no other alternative to crushing their medications. Pharmaceutical companies could be urged to develop specifi c "older adult-friendly" medicines in line with "child-friendly" medicines in an effort to minimize the risks of crushing medications. (Ewan et al., 2010; Socransky et al., 2013; Diaz, Strausbaugh & Dongari-Bagtzoglou, 2014; Chevalier, Ranque & Prêcheur, 2017) 
Healthy oral biofilm
Oral streptococci are early tooth colonizers, via specific attachment to the salivary pellicle composed of hostderived proteins and glycoproteins. Their main nutrients are saliva and dietary sugars.
Common species: Parvimonas micra, Rothia mucilaginosa, Streptococcus spp. (S. oralis, S. gordonii, S. mitis, S. mutans, S. salivarius, S. sanguinis), Veillonella spp. (V. atypica, V. dispar, V. parvula) .
Cariogenic biofilm
Streptococcus, Actinomyces and Lactobacillus spp. are cariogenic. S. mutans has the most active virulence factors: 1) Phosphoenolpyruvate system: quick utilization of any trace of sugar in the environment.
2) Glycolytic system (glycosyl hydrolases): acid production and enamel-dentin lysis, via -The homofermentative pathway, activated by exogenous sugars and anaerobic conditions (thick dental plaque or cavities). Yields >80% lactic acid residues from glucose, lowering pH to under 5.5.
-The heterofermentative pathway, less aggressive for tooth, activated by aerobic conditions, sugar shortage or alkaline pH. Yields lactic, acetic, butyric, propionic and formic acids. 
